Children's Health Defense Text Logo
CHD-TV Logo
X icon
Rumble Icon
DonateBecome an Insider
CHD-TV Logo
HomeShowsEventsMoviesThe People's StudyArchiveGet AlertsContact UsSearch icon
CHD Logo

Children's Health Defense® is a 501(c)(3) non-profit organization. Our mission is ending childhood health epidemics by eliminating toxic exposure. We will restore and protect the health of children by eliminating environmental exposures, holding responsible parties accountable, and establishing safeguards to prevent future harm of children's health.  Protecting Children. Exposing Harms. Seeking Justice.

Substack Social Media Icon
Take Action
DonateJoin Our ListBecome an Insider

Donations are tax deductible to the full extent of the law. EIN #26-0388604

  • •Children's Health Defense
  • •Legal Disclaimer
  • •Terms of Use
  • •Privacy Policy
  • •Donate
  • •Work for CHD
  • •Contact
  • •Social

© 2016 - 2026 Children's Health Defense® • All Rights Reserved

Event Home

chat

Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices | May 22

*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.

DonateJoin Our List

chat

‘Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) announced a hearing titled "Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices."

‘“America remains the leader in developing cutting edge biomedical innovation. Countries around the globe look to the FDA for guidance on facilitating safe and effective treatments and medical devices,” said Chairs Rodgers and Guthrie.

‘“Given the increased funding provided in the most recent user fee reauthorization, it’s important that we engage regularly with key FDA officials to better understand what’s working well at the FDA and what challenges persist. Continuing to rebuild public trust in government health agencies is critical and will require more transparency from agencies like the FDA.”

‘Subcommittee on Health hearing titled "Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices."’

WITNESSES:

  • Patrizia Cavazzoni, M.D. — Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration
  • Peter Marks, M.D., Ph.D. — *Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration
  • Jeffrey Shuren, M.D., J.D. — Director, Center for Devices and Radiological Health (CDRH), Food and Drug Administration

Related Videos

Fiscal Year 2025 Budget Request for the Food and Drug Administration | Apr. 18

Fiscal Year 2025 Budget Request for the Food and Drug Administration | Apr. 18

FDA VRBPAC Meeting | Influenza Vaccines, Avian Flu + Research Program Updates | Oct. 10

FDA VRBPAC Meeting | Influenza Vaccines, Avian Flu + Research Program Updates | Oct. 10

Evaluating FDA Human Foods and Tobacco Programs | Sept. 10

Evaluating FDA Human Foods and Tobacco Programs | Sept. 10

Oversight of the U.S. Food and Drug Administration | Apr. 11

Oversight of the U.S. Food and Drug Administration | Apr. 11

Login